Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes
Top Cited Papers
- 1 September 2003
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 24 (9) , 441-443
- https://doi.org/10.1016/s0165-6147(03)00206-2
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Inhibitory Phosphorylation of Glycogen Synthase Kinase-3 (GSK-3) in Response to LithiumJournal of Biological Chemistry, 2003
- Glycogen Synthase Kinase 3β Is a Natural Activator of Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase Kinase 1 (MEKK1)Journal of Biological Chemistry, 2003
- Cdc42 regulates GSK-3β and adenomatous polyposis coli to control cell polarityNature, 2003
- Lithium Ameliorates HIV-gp120-Mediated NeurotoxicityMolecular and Cellular Neuroscience, 2002
- Lithium blocks the PKB and GSK3 dephosphorylation induced by ceramide through protein phosphatase-2ACellular Signalling, 2002
- Role of Translation Initiation Factor 2B in Control of Cell Survival by the Phosphatidylinositol 3-Kinase/Akt/Glycogen Synthase Kinase 3β Signaling PathwayMolecular and Cellular Biology, 2002
- The renaissance of GSK3Nature Reviews Molecular Cell Biology, 2001
- The multifaceted roles of glycogen synthase kinase 3β in cellular signalingPublished by Elsevier ,2001
- Molecular Targets of Lithium ActionAnnual Review of Pharmacology and Toxicology, 2001
- Lithium Inhibits Glycogen Synthase Kinase-3 by Competition for MagnesiumBiochemical and Biophysical Research Communications, 2001